To understand how the intervention groups developed alleviated scopolamine-induced cognitive impairment, we examined the expression levels of genes associated with the PI3K-AKT signaling, cholinergic signaling, and folate biosynthesis pathways in the hippocampus. This evidence concerns the gene AKT1 and Cognitive impairment.